Bleiben Sie auf dem Laufenden mit den neuesten Erkenntnissen und Fortschritten aus unserem Forschungslabor

Bleiben Sie auf dem neuesten Stand, wie unsere Arbeit
die Zukunft der Gesundheitsfürsorge für Atemwegserkrankungen prägt.

Jahr:
2024
Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
Autoren
Kidane, F. A., Muller, L., Rocha-Hasler, M., Tu, A., Stanek, V., Campion, N., Bartosik, T., Zghaebi, M., Stoshikj, S., Gompelmann, D., Spittler, A., Idzko, M., Eckl-Dorna, J., & Schneider, S.
Referenz
Clin Immunol, 110174. doi:10.1016/j.clim.2024.110174
Publikation lesen
Jahr:
2023
Nasal IL-13 production identifies patients with late phase allergic responses
Autoren
Campion, N. J., Villazala-Merino, S., Thwaites, R. S., Stanek, V., Fd, H. K., Pertsinidou, E., Zghaebi, M., Toth, J., Froschl, R., Perkmann, T., Gangl, K., Schneider, S., Ristl, R., Scott, I. C., Cohen, E. S., Molin, M., Focke-Tejkl, M., Regelsberger, G., Hansel, T. T., Valenta, R., Eckl-Dorna, J., & Niederberger-Leppin, V.
Referenz
J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.06.026
Publikation lesen
Jahr:
2024
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Autoren
Seys, S.F., Schneider, S., de Kinderen, J., Reitsma, S., Cavaliere, C., Tomazic, P.V., Morgenstern, C. , Mortuaire, G., Wagenmann, M., Bettio, G., Ciofalo, A., Diamant, Z., Eckl-Dorna, J., Fokkens, W.J., Holzmeister, C., Marien, G., Masieri, S., Otten, J., Scheckenbach, K., Tu, A., Bachert, C., CHRINOSOR consortium
Referenz
J Allergy Clin Immunol online ahead of print. doi: 10.1016/j.jaci.2024.10.016.
Publikation lesen
Nach Jahr filtern:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jahr:
2024
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Autoren
Seys, S.F., Schneider, S., de Kinderen, J., Reitsma, S., Cavaliere, C., Tomazic, P.V., Morgenstern, C. , Mortuaire, G., Wagenmann, M., Bettio, G., Ciofalo, A., Diamant, Z., Eckl-Dorna, J., Fokkens, W.J., Holzmeister, C., Marien, G., Masieri, S., Otten, J., Scheckenbach, K., Tu, A., Bachert, C., CHRINOSOR consortium
Referenz
J Allergy Clin Immunol online ahead of print. doi: 10.1016/j.jaci.2024.10.016.
Jahr:
2024
Patient-reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease status
Autoren
Cotter, R.A., Garcia, J.T., Alsayed, A., Schneider, S., Liu, D.T., Eckl-Dorna, J., Houssein, F.A., Boparai, R.S., Parail, N.A., Chu, M.M., Meier, J.C., Alsaleh, S., Phillips, K.M., & Sedaghat, A.R.
Referenz
http://Int Forum Allergy Rhinol, Online ahead of print. doi: 10.1002/alr.23435.
Jahr:
2008
B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
Autoren
Barral, P., Eckl-Dorna, J., Harwood, N. E., De Santo, C., Salio, M., Illarionov, P., Besra, G. S., Cerundolo, V., & Batista, F. D.
Referenz
Proc Natl Acad Sci U S A, 105(24), 8345-8350. doi:10.1073/pnas.0802968105
Jahr:
2007
The role of integrins and coreceptors in refining thresholds for B-cell responses
Autoren
Batista, F. D., Arana, E., Barral, P., Carrasco, Y. R., Depoil, D., Eckl-Dorna, J., Fleire, S., Howe, K., Vehlow, A., Weber, M., & Treanor, B.
Referenz
Immunol Rev, 218, 197-213. doi:10.1111/j.1600-065X.2007.00540.x
Jahr:
2009
BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.
Autoren
Eckl-Dorna, J., & Batista, F. D.
Referenz
Blood, 113(17), 3969-3977. doi:10.1182/blood-2008-10-185421
Jahr:
2010
Exposure of rye (Secale cereale) cultivars to elevated ozone levels increases the allergen content in pollen
Autoren
Eckl-Dorna, J., Klein, B., Reichenauer, T. G., Niederberger, V., & Valenta, R.
Referenz
J Allergy Clin Immunol, 126(6), 1315-1317. doi:10.1016/j.jaci.2010.06.012
Jahr:
2011
Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses
Autoren
Reginald, K., Westritschnig, K., Linhart, B., Focke-Tejkl, M., Jahn-Schmid, B., Eckl-Dorna, J., Heratizadeh, A., Stocklinger, A., Balic, N., Spitzauer, S., Niederberger, V., Werfel, T., Thalhamer, J., Weidinger, S., Novak, N., Ollert, M., Hirschl, A. M., & Valenta, R.
Referenz
J Allergy Clin Immunol, 128(1), 82-91 e88. doi:10.1016/j.jaci.2011.02.034
Jahr:
2013
An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy
Autoren
Selb, R., Eckl-Dorna, J., Vrtala, S., Valenta, R., & Niederberger, V.
Referenz
Allergy, 68(9), 1199-1202. doi:10.1111/all.12204
Jahr:
2012
The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells
Autoren
Eckl-Dorna, J., Pree, I., Reisinger, J., Marth, K., Chen, K. W., Vrtala, S., Spitzauer, S., Valenta, R., & Niederberger, V.
Referenz
Clin Exp Allergy, 42(9), 1347-1355. doi:10.1111/j.1365-2222.2012.04030.x
Jahr:
2012
Basophils are not the key antigen-presenting cells in allergic patients
Autoren
Eckl-Dorna, J., Ellinger, A., Blatt, K., Ghanim, V., Steiner, I., Pavelka, M., Valent, P., Valenta, R., & Niederberger, V.
Referenz
Allergy, 67(5), 601-608. doi:10.1111/j.1398-9995.2012.02792.x
Jahr:
2012
Natural killer cell-mediated augmentation of autoantibody production?
Autoren
Eckl-Dorna, J.
Referenz
J Leukoc Biol, 92(4), 695-697. doi:10.1189/jlb.0512254
Jahr:
2015
Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
Autoren
Madritsch, C., Eckl-Dorna, J., Blatt, K., Ellinger, I., Kundi, M., Niederberger, V., Valent, P., Valenta, R., & Flicker, S.
Referenz
J Allergy Clin Immunol, 136(2), 490-493 e411. doi:10.1016/j.jaci.2015.01.006
Jahr:
2013
Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE
Autoren
Reginald, K., Eckl-Dorna, J., Zafred, D., Focke-Tejkl, M., Lupinek, C., Niederberger, V., Keller, W., & Valenta, R.
Referenz
Immunol Cell Biol, 91(2), 167-172. doi:10.1038/icb.2012.70
Jahr:
2013
What is the source of serum allergen-specific IgE?
Autoren
Eckl-Dorna, J., & Niederberger, V.
Referenz
Curr Allergy Asthma Rep, 13(3), 281-287. doi:10.1007/s11882-013-0348-x
Jahr:
2016
Omalizumab's Impact on Total and Allergen-Specific IgE Levels: A Polyclonal Story
Autoren
Eckl-Dorna, J.
Referenz
Int Arch Allergy Immunol, 169(2), 69-70. doi:10.1159/000444998
Jahr:
2014
Recombinant allergen-based provocation testing
Autoren
Niederberger, V., Eckl-Dorna, J., & Pauli, G
Referenz
Methods, 66(1), 96-105. doi:10.1016/j.ymeth.2013.07.037
Jahr:
2015
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients
Autoren
Niederberger, V., Marth, K., Eckl-Dorna, J., Focke-Tejkl, M., Weber, M., Hemmer, W., Berger, U., Neubauer, A., Stolz, F., Henning, R., & Valenta, R.
Referenz
J Allergy Clin Immunol, 136(4), 1101-1103 e1108. doi:10.1016/j.jaci.2015.03.034
Jahr:
2017
CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells
Autoren
Selb, R., Eckl-Dorna, J., Neunkirchner, A., Schmetterer, K., Marth, K., Gamper, J., Jahn-Schmid, B., Pickl, W. F., Valenta, R., & Niederberger, V.
Referenz
J Allergy Clin Immunol, 139(1), 290-299 e294. doi:10.1016/j.jaci.2016.03.042
Jahr:
2015
Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines
Autoren
Kotowski, U., Heiduschka, G., Seemann, R., Eckl-Dorna, J., Schmid, R., Kranebitter, V., Stanisz, I., Brunner, M., Lill, C., & Thurnher, D.
Referenz
Strahlenther Onkol, 191(6), 511-517. doi:10.1007/s00066-014-0807-x
Jahr:
2018
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study
Autoren
Eckl-Dorna, J., Froschl, R., Lupinek, C., Kiss, R., Gattinger, P., Marth, K., Campana, R., Mittermann, I., Blatt, K., Valent, P., Selb, R., Mayer, A., Gangl, K., Steiner, I., Gamper, J., Perkmann, T., Zieglmayer, P., Gevaert, P., Valenta, R., & Niederberger, V.
Referenz
Allergy, 73(5), 1003-1012. doi:10.1111/all.13343
Jahr:
2015
Two types of BCR interactions are positively selected during leukemia development in the Emu-TCL1 transgenic mouse model of CLL
Autoren
Iacovelli, S., Hug, E., Bennardo, S., Duehren-von Minden, M., Gobessi, S., Rinaldi, A., Suljagic, M., Bilbao, D., Bolasco, G., Eckl-Dorna, J., Niederberger, V., Autore, F., Sica, S., Laurenti, L., Wang, H., Cornall, R. J., Clarke, S. H., Croce, C. M., Bertoni, F., Jumaa, H., & Efremov, D. G.
Referenz
Blood, 125(10), 1578-1588. doi:10.1182/blood-2014-07-587790
Jahr:
2015
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Autoren
Focke-Tejkl, M., Weber, M., Niespodziana, K., Neubauer, A., Huber, H., Henning, R., Stegfellner, G., Maderegger, B., Hauer, M., Stolz, F., Niederberger, V., Marth, K., Eckl-Dorna, J., Weiss, R., Thalhamer, J., Blatt, K., Valent, P., & Valenta, R.
Referenz
J Allergy Clin Immunol, 135(5), 1207-1207 e1201-1211. doi:10.1016/j.jaci.2014.09.012
Jahr:
2016
Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay
Autoren
Eckl-Dorna, J., Campana, R., Valenta, R., & Niederberger, V.
Referenz
Allergy, 70(10), 1222-1229. doi:10.1111/all.12661
Jahr:
2017
Critical and direct involvement of the CD23 stalk region in IgE binding
Autoren
Selb, R., Eckl-Dorna, J., Twaroch, T. E., Lupinek, C., Teufelberger, A., Hofer, G., Focke-Tejkl, M., Gepp, B., Linhart, B., Breiteneder, H., Ellinger, A., Keller, W., Roux, K. H., Valenta, R., & Niederberger, V.
Referenz
J Allergy Clin Immunol, 139(1), 281-289 e285. doi:10.1016/j.jaci.2016.04.015
Jahr:
2018
Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function
Autoren
Waltl, E. E., Selb, R., Eckl-Dorna, J., Mueller, C. A., Cabauatan, C. R., Eiwegger, T., Resch-Marat, Y., Niespodziana, K., Vrtala, S., Valenta, R., & Niederberger, V.
Referenz
Sci Rep, 8(1), 9688. doi:10.1038/s41598-018-27022-y
Jahr:
2018
Molecular Aspects of Allergens and Allergy
Autoren
Valenta, R., Karaulov, A., Niederberger, V., Gattinger, P., van Hage, M., Flicker, S., Linhart, B., Campana, R., Focke-Tejkl, M., Curin, M., Eckl-Dorna, J., Lupinek, C., Resch-Marat, Y., Vrtala, S., Mittermann, I., Garib, V., Khaitov, M., Valent, P., & Pickl, W. F.
Referenz
Adv Immunol, 138, 195-256. doi:10.1016/bs.ai.2018.03.002
Jahr:
2018
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32
Autoren
Niederberger, V., Neubauer, A., Gevaert, P., Zidarn, M., Worm, M., Aberer, W., Malling, H. J., Pfaar, O., Klimek, L., Pfutzner, W., Ring, J., Darsow, U., Novak, N., Gerth van Wijk, R., Eckl-Dorna, J., Focke-Tejkl, M., Weber, M., Muller, H. H., Klinger, J., Stolz, F., Breit, N., Henning, R., & Valenta, R.
Referenz
J Allergy Clin Immunol, 142(2), 497-509 e499. doi:10.1016/j.jaci.2017.09.052
Jahr:
2019
Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response
Autoren
Eckl-Dorna, J., Weber, M., Stanek, V., Linhart, B., Ristl, R., Waltl, E. E., Villazala-Merino, S., Hummel, A., Focke-Tejkl, M., Froeschel, R., Neubauer, A., Henning, R., Perkmann, T., Valenta, R., & Niederberger, V.
Referenz
EBioMedicine, 50, 421-432. doi:10.1016/j.ebiom.2019.11.006
Jahr:
2019
Tracing IgE-Producing Cells in Allergic Patients
Autoren
Eckl-Dorna, J., Villazala-Merino, S., Campion, N. J., Byazrova, M., Filatov, A., Kudlay, D., Karsonova, A., Riabova, K., Khaitov, M., Karaulov, A., Niederberger-Leppin, V., & Valenta, R.
Referenz
Cells, 8(9). doi:10.3390/cells8090994
Jahr:
2019
Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
Autoren
Eckl-Dorna, J., Villazala-Merino, S., Linhart, B., Karaulov, A. V., Zhernov, Y., Khaitov, M., Niederberger-Leppin, V., & Valenta, R.
Referenz
Front Immunol, 9, 3131. doi:10.3389/fimmu.2018.03131
Jahr:
2020
Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier Function
Autoren
Waltl, E. E., Stanek, V., Mueller, C. A., Kiss, R., Eckl-Dorna, J., Valenta, R., & Niederberger, V.
Referenz
Allergy Asthma Immunol Res, 12(2), 364-370. doi:10.4168/aair.2020.12.2.364
Jahr:
2020
Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation
Autoren
Villazala-Merino, S., Rodriguez-Dominguez, A., Stanek, V., Campion, N. J., Gattinger, P., Hofer, G., Froeschl, R., Fae, I., Lupinek, C., Vrtala, S., Breiteneder, H., Keller, W., Perkmann, T., Nakamura, R., Pickl, W. F., Valenta, R., Eckl-Dorna, J., & Niederberger, V.
Referenz
J Allergy Clin Immunol, 145(3), 958-967 e955. doi:10.1016/j.jaci.2019.11.019
Jahr:
2023
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
Autoren
Seys, S. F., Hellings, P. W., Alobid, I., Backer, V., Bequignon, E., von Buchwald, C., Cavaliere, C., Coste, A., Deneyer, L., Diamant, Z., Eckl-Dorna, J., Fokkens, W. J., Gane, S., Gevaert, P., Holbaek-Haase, C., Holzmeister, C., Hopkins, C., Hox, V., Huart, C., Jankowski, R., Jorissen, M., Kjeldsen, A., Knipps, L., Lange, B., van der Lans, R., Laulajainen-Hongisto, A., Larsen, K., Liu, D. T., Lund, V., Marien, G., Masieri, S., Mortuaire, G., Mullol, J., Reitsma, S., Rombaux, P., Schneider, S., Steinsvik, A., Tomazic, P. V., Toppila-Salmi, S. K., Van Gerven, L., Van Zele, T., Virkkula, P., Wagenmann, M., & Bachert, C.
Referenz
J Allergy Clin Immunol Pract, 11(2), 431-438 e432. doi:10.1016/j.jaip.2022.09.043
Jahr:
2020
Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease
Autoren
Schneider, S., Campion, N. J., Villazala-Merino, S., Liu, D. T., Bartosik, T., Landegger, L. D., Ahmadi, N., Mueller, C. A., Vyskocil, E., Stanek, V., Quint, T., Bangert, C., & Eckl-Dorna, J.
Referenz
J Clin Med, 9(4). doi:10.3390/jcm9040925
Jahr:
2020
A Novel Variant in the TBC1D24 Lipid-Binding Pocket Causes Autosomal Dominant Hearing Loss: Evidence for a Genotype-Phenotype Correlation
Autoren
Parzefall, T., Frohne, A., Koenighofer, M., Neesen, J., Laccone, F., Eckl-Dorna, J., Waters, J. J., Schreiner, M., Amr, S. S., Ashton, E., Schoefer, C., Gstoettner, W., Frei, K., & Lucas, T.
Referenz
Front Cell Neurosci, 14, 585669. doi:10.3389/fncel.2020.585669
Jahr:
2020
Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma
Autoren
Foki, E., Gangl, K., Kranebitter, V., Niederberger-Leppin, V., Eckl-Dorna, J., Wiebringhaus, R., Thurnher, D., & Heiduschka, G.
Referenz
Head Neck, 42(9), 2348-2354. doi:10.1002/hed.26247
Jahr:
2020
Highly sensitive ELISA-based assay for quantification of allergen-specific IgE antibody levels
Autoren
Karsonova, A., Riabova, K., Villazala-Merino, S., Campana, R., Niederberger, V., Eckl-Dorna, J., Froschl, R., Perkmann, T., Zhernov, Y. V., Elisyutina, O. G., Fedenko, E. S., Khaitov, M. R., Fomina, D., Beltiukov, E., van Hage, M., Gronlund, H., Valenta, R., Karaulov, A., & Curin, M.
Referenz
Allergy, 75(10), 2668-2670. doi:10.1111/all.14325
Jahr:
2021
Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
Autoren
Zghaebi, M., Byazrova, M., Flicker, S., Villazala-Merino, S., Campion, N. J., Stanek, V., Tu, A., Breiteneder, H., Filatov, A., Khaitov, M., Niederberger-Leppin, V., Eckl-Dorna, J., & Valenta, R.
Referenz
Front Immunol, 12, 803236. doi:10.3389/fimmu.2021.803236
Jahr:
2021
Functional iron-deficiency in women with allergic rhinitis is associated with symptoms after nasal provocation and lack of iron-sequestering microbes
Autoren
Petje, L. M., Jensen, S. A., Szikora, S., Sulzbacher, M., Bartosik, T., Pjevac, P., Hausmann, B., Hufnagl, K., Untersmayr, E., Fischer, L., Vyskocil, E., Eckl-Dorna, J., Jensen-Jarolim, E., Hofstetter, G., Afify, S. M., Krenn, C. G., Roth, G. A., Rivelles, E., Hann, S., & Roth-Walter, F.
Referenz
Allergy, 76(9), 2882-2886. doi:10.1111/all.14960
Jahr:
2021
Prevalence and Symptom Burden of Nasal Polyps in a Large Austrian Population
Autoren
Campion, N. J., Kohler, R., Ristl, R., Villazala-Merino, S., Eckl-Dorna, J., & Niederberger-Leppin, V.
Referenz
J Allergy Clin Immunol Pract, 9(11), 4117-4129 e4112. doi:10.1016/j.jaip.2021.06.037
Jahr:
2021
Differences in men and women suffering from CRSwNP and AERD in quality of life
Autoren
Bartosik, T. J., Liu, D. T., Campion, N. J., Villazala-Merino, S., Janik, S., Dahm, V., Mueller, C. A., Vyskocil, E., Stanek, V., Quint, T., Bangert, C., Eckl-Dorna, J., & Schneider, S.
Referenz
Eur Arch Otorhinolaryngol, 278(5), 1419-1427. doi:10.1007/s00405-020-06418-5
Jahr:
2021
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
Autoren
Akinfenwa, O., Huang, H. J., Linhart, B., Focke-Tejkl, M., Vrtala, S., Poroshina, A., Nikonova, A., Khaitov, M., Campion, N. J., Eckl-Dorna, J., Niederberger-Leppin, V., Kratzer, B., Tauber, P. A., Pickl, W. F., Kundi, M., Campana, R., & Valenta, R.
Referenz
Front Immunol, 12, 744544. doi:10.3389/fimmu.2021.744544
Jahr:
2022
Ameliorating Atopy by Compensating Micronutritional Deficiencies in Immune Cells: A Double-Blind Placebo-Controlled Pilot Study
Autoren
Bartosik, T., Jensen, S.A., Afify, S.M., Bianchini, R., Hufnagl, K., Hofstetter, G., Berger, M., Bastl, M., Berger, U., Rivelles, E., Schmetterer, K., Eckl-Dorna, J., Brkic, F.F., Vyskocil, E., Guethoff, S., Graessel, A., Kramer, M.F., Jensen-Jarolim, E., & Roth-Walter, F.
Referenz
J Allergy Clin Immunol Pract. 10(7):1889-1902.e9. doi: 10.1016/j.jaip.2022.02.028.
Jahr:
2022
Annual trends in Google searches provides insights related to rhinosinusitis exacerbations
Autoren
Liu, D. T., Schally, M., Schneider, S., Eckl-Dorna, J., Phillips, K. M., Mueller, C. A., Sedaghat, A. R., & Besser, G.
Referenz
Eur Arch Otorhinolaryngol, 279(1), 213-223. doi:10.1007/s00405-021-06806-5
Jahr:
2022
Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment
Autoren
Zettl, I., Ivanova, T., Zghaebi, M., Rutovskaya, M. V., Ellinger, I., Goryainova, O., Kollarova, J., Villazala-Merino, S., Lupinek, C., Weichwald, C., Drescher, A., Eckl-Dorna, J., Tillib, S. V., & Flicker, S.
Referenz
Front Immunol, 13, 1022418. doi:10.3389/fimmu.2022.1022418
Jahr:
2022
Using mass cytometry for the analysis of samples of the human airways
Autoren
Rocha-Hasler, M., Muller, L., Wagner, A., Tu, A., Stanek, V., Campion, N. J., Bartosik, T., Zghaebi, M., Stoshikj, S., Gompelmann, D., Zech, A., Mei, H., Kratochwill, K., Spittler, A., Idzko, M., Schneider, S., & Eckl-Dorna, J.
Referenz
Front Immunol, 13, 1004583. doi:10.3389/fimmu.2022.1004583
Jahr:
2022
Identification of apple cultivars hypoallergenic for birch pollen-allergic individuals by a multidisciplinary in vitro and in vivo approach
Autoren
Strobl, M. R., Vollmann, U., Eckl-Dorna, J., Radakovics, A., Ibl, V., Schnurer, M., Brenner, M., Dermendjiev, G., Weckwerth, W., Neumuller, M., Frommlet, F., Demir, H., Bublin, M., Muller, C., & Bohle, B.
Referenz
Clin Transl Allergy, 12(8), e12186. doi:10.1002/clt2.12186
Jahr:
2022
Chronic rhinosinusitis symptoms differentially impact the likelihood of major depressive disorders.
Autoren
Liu, D. T., Bartosik, T. J., Campion, N. J., Bayer, K., Tu, A., Victoria, S., Besser, G., Mueller, C. A., Gangl, K., Eckl-Dorna, J., & Schneider, S.
Referenz
Laryngoscope Investig Otolaryngol, 7(1), 29-35. doi:10.1002/lio2.733
Jahr:
2024
Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy
Autoren
Mengrelis, K., Niederacher, G., Prickler, L., Kainz, V., Weijler, A. M., Rudolph, E., Stanek, V., Eckl-Dorna, J., Baranyi, U., Spittler, A., Focke-Tejkl, M., Bohle, B., Valenta, R., Becker, C. F. W., Wekerle, T., & Linhart, B.
Referenz
Cells, 13(5). doi:10.3390/cells13050446
Jahr:
2022
Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease
Autoren
Bangert, C., Villazala-Merino, S., Fahrenberger, M., Krausgruber, T., Bauer, W. M., Stanek, V., Campion, N. J., Bartosik, T., Quint, T., Regelsberger, G., Niederberger-Leppin, V., Bock, C., Schneider, S., & Eckl-Dorna, J.
Referenz
Front Immunol, 13, 850494. doi:10.3389/fimmu.2022.850494
Jahr:
2023
Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
Autoren
Weichwald, C., Zettl, I., Ellinger, I., Niespodziana, K., Waltl, E. E., Villazala-Merino, S., Ivanov, D., Eckl-Dorna, J., Niederberger-Leppin, V., Valenta, R., & Flicker, S.
Referenz
Int J Mol Sci, 24(3). doi:10.3390/ijms24032725
Jahr:
2023
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
Autoren
Schneider, S., Poglitsch, K., Morgenstern, C., Quint, T., Gangl, K., Sinz, C., Bartosik, T., Campion, N. J., Liu, D. T., Landegger, L. D., Tu, A., Stanek, V., Rocha-Hasler, M., Bangert, C., & Eckl-Dorna, J.
Referenz
Eur Respir J, 61(3). doi:10.1183/13993003.01335-2022
Jahr:
2023
Pitfalls in sampling and analyzing low-biomass human nasal microbiome samples
Autoren
Pjevac, P., Bartosik, T., Schneider, S., & Eckl-Dorna, J.
Referenz
J Allergy Clin Immunol, 152(1), 304. doi:10.1016/j.jaci.2023.04.001
Jahr:
2023
Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis
Autoren
Chromy, D., Bartosik, T., Brkic, F. F., Quint, T., Tu, A., Eckl-Dorna, J., Schneider, S., & Bangert, C.
Referenz
J Dermatol, 50(1), 89-93. doi:10.1111/1346-8138.16595
Jahr:
2023
Nasal IL-13 production identifies patients with late phase allergic responses
Autoren
Campion, N. J., Villazala-Merino, S., Thwaites, R. S., Stanek, V., Fd, H. K., Pertsinidou, E., Zghaebi, M., Toth, J., Froschl, R., Perkmann, T., Gangl, K., Schneider, S., Ristl, R., Scott, I. C., Cohen, E. S., Molin, M., Focke-Tejkl, M., Regelsberger, G., Hansel, T. T., Valenta, R., Eckl-Dorna, J., & Niederberger-Leppin, V.
Referenz
J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.06.026
Jahr:
2023
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production
Autoren
Campion, N. J., Doralt, A., Lupinek, C., Berger, M., Poglitsch, K., Brugger, J., Quint, T., Gangl, K., Sinz, C., Bartosik, T., Liu, D. T., Landegger, L. D., Tu, A., Stanek, V., Berger, U., Bangert, C., Schneider, S., & Eckl-Dorna, J.
Referenz
Allergy. doi:10.1111/all.15653
Jahr:
2023
The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
Autoren
Campion, N. J., Brugger, J., Tu, A., Stanek, V., Brkic, F. F., Bartosik, T. J., Liu, D. T., Hoehl, B. S., Gangl, K., Eckl-Dorna, J., & Schneider, S.
Referenz
J Otolaryngol Head Neck Surg, 52(1), 56. doi:10.1186/s40463-023-00663-4
Jahr:
2023
The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids
Autoren
Bartosik, T. J., Campion, N. J., Freisl, K., Liu, D. T., Gangl, K., Stanek, V., Tu, A., Pjevac, P., Hausmann, B., Eckl-Dorna, J., & Schneider, S.
Referenz
Front Immunol, 14, 1112345. doi:10.3389/fimmu.2023.1112345
Jahr:
2023
Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD
Autoren
Brkic, F. F., Liu, D. T., Klimbacher, R., Campion, N. J., Bartosik, T. J., Vyskocil, E., Stanek, V., Tu, A., Arnoldner, T., Bangert, C., Gangl, K., Eckl-Dorna, J., & Schneider, S.
Referenz
Rhinology, 61(4), 320-327. doi:10.4193/Rhin22.408
Jahr:
2024
Trimeric Bet v 1-specific nanobodies cause strong suppression of IgE binding
Autoren
Bauernfeind, C., Zettl, I., Ivanova, T., Goryainova, O., Weijler, A.M., Pranz, B., Drescher, A., Focke-Tejkl, M., Pavkov-Keller, T., Eckl-Dorna, J., Tillib, S.V.,& Flicker, S.
Referenz
Front Immunol, 15:1343024. doi: 10.3389/fimmu.2024.1343024. eCollection 2024
Jahr:
2024
Overall symptom severity as a patient-reported outcome measure for chronic rhinosinusitis: what it reflects and how to measure it
Autoren
Garcia, J.T., Cotter, R.A., Boparai, R.S., Alsayed, A., Schneider, S., Liu, D.T., Eckl-Dorna, J., Parail, N.A., Houssein, F.A., Chu, M.M., Meier, J.C., Alsaleh, S., Phillips, K.M., & Sedaghat, A.R.
Referenz
Rhinology, online ahead of print. doi: 10.4193/Rhin24.145.
Jahr:
2024
Modulation of Bronchial Epithelial Barrier Integrity by Low Molecular Weight Components from Birch Pollen
Autoren
Sudharson, S., Kalic, T., Eckl-Dorna, J., Lengger, N., Breiteneder, H., & Hafner C.
Referenz
Int J Mol Sci, 25(13):7374. doi: 10.3390/ijms25137374.
Jahr:
2024
Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
Autoren
Kidane, F. A., Muller, L., Rocha-Hasler, M., Tu, A., Stanek, V., Campion, N., Bartosik, T., Zghaebi, M., Stoshikj, S., Gompelmann, D., Spittler, A., Idzko, M., Eckl-Dorna, J., & Schneider, S.
Referenz
Clin Immunol, 110174. doi:10.1016/j.clim.2024.110174
Jahr:
2024
Real-Life Study of Patient Preference for Dupilumab or Revision Surgery for Recurrent Chronic Rhinosinusitis with Nasal Polyps
Autoren
Gangl, K., Liu, D. T., Bartosik, T., Campion, N. J., Vyskocil, E., Mueller, C. A., Knerer, B., Eckl-Dorna, J., & Schneider, S.
Referenz
J Pers Med, 14(4). doi:10.3390/jpm14040338